<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>ZIKV isolation and sequencing</italic> -The serum samples were obtained from two patients living in Natal, Rio Grande do Norte state (RN)/Northern Brazil (latitude: 05º 47’ 51’’ S; longitude: 35º 13’ 34’’ W) in March (strain ZV BR 2015/15098) and in June (strain ZV BR 2015/15261) of 2015, during the beginning of the outbreak in Brazil. The other sample (strain ZV BR 2016/16288) was obtained from a patient living in Teutônia in Rio Grande do Sul state (RS)/South Brazil (latitude: 29º 28’ 18” S; longitude: 51º 49’ 00’’ W) in February of 2016. The use of these samples was approved by Fiocruz and the Brazilian National Ethics Committee of Human Experimentation (CAAE: 42481115.7.0000.5248). The laboratory diagnosis of acute ZIKV infection was confirmed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
 <xref rid="B10" ref-type="bibr">
  <sup>10</sup>
 </xref> Additionally, the sera were negative for anti-ZIKV IgM using an in-house enzyme-linked immunosorbent assay (ELISA) based on a previously described methodology.
 <xref rid="B11" ref-type="bibr">
  <sup>11</sup>
 </xref>
</p>
